Search
Kymera Therapeutics Inc
KYMRAdd to Watchlist
116.995USD
+7.675+7.02%
Market hours （ET）Quotes delayed by 15 min
9.61BMarket Cap
LossP/E TTM
Kymera Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-29The current valuation score of Kymera Therapeutics Inc is 9.10, ranking 54 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -30.57, which is -87.47% below the recent high of -3.83 and -6.53% above the recent low of -32.56.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
